Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
'Spring Clean' Your Finances: Three Things You Can Do Today!
Spring has sprung! Time to tackle more than your garden.
Long Live! Eagles Center Jason Kelce Retires After 13 NFL Seasons
Time for Kylie to get that cat?
Supreme Court Restores Trump to Ballot, Overriding State Attempts For Ban
The U.S. Supreme Court unanimously decided Monday to restore former president Donald Trump to 2024 presidential primary ballots. The court Monday rejected state attempts to hold the Republican former president accountable for the Capitol riot.
These Are the Absolute Best Destinations for Spring Break Camping
With warmer days and holidays ahead, it’s time to start planning.
JetBlue and Spirit End Merger Plan — Leaving Customers Dispirited and Blue
JetBlue and Spirit Airlines are ending their proposed $3.8 billion merger after a federal judge blocked the deal, ruling it would hurt competition.
Forget Timothée and Zendaya: Dune Is All About Supply-Chain Issues
The collapse of our own global economy as explained by "Dune."
Voyager Ventures Has Confidence Sustainable Tech Is Just Better
Voyager Ventures founding partners Sarah Sclarsic and Sierra Peterson discuss how they choose products and companies to invest in, and why there’s such high demand for sustainable tech.
Turning Ocean Waves Into Clean Energy
Inna Braverman, co-founder of Eco Wave Power, shares how her company’s tech works, plus the role governments should play in adopting clean energy.
🎶 It's the Most Wonderful Time of the Year🎶: IRS Launches Crackdown on Wealthy ‘non-filers’
You can run but you can't hide.
